Literature DB >> 2283380

Determination of alpha-tocopherol, free cholesterol, esterified cholesterols and triacylglycerols in human lipoproteins by high-performance liquid chromatography.

K Seta1, H Nakamura, T Okuyama.   

Abstract

The determination of alpha-tocopherol, free cholesterol, esterified cholesterols and triacylglycerols in human plasma and in fractions containing individual lipoproteins was achieved by reversed-phase high-performance liquid chromatography (HPLC). The lipoprotein fractions, such as chylomicron, VLDL, LDL, HDL2 and HDL3, were collected by ultracentrifugation of human plasma. The chromatographic separation was accomplished with a column packed with Hitachi Gel 3057, which is a spherical octadecylsilica of particle size 3 microns. The mobile phase was acetonitrile-2-propanol (75:25, v/v), and the eluate was monitored with ultraviolet absorption and fluorescence detectors connected in series. Qualitative analysis of the main chromatographic peaks collected during the HPLC of a plasma sample was done with the use of field-desorption mass spectrometry. The determination analysis of alpha-tocopherol, free cholesterol and esterified cholesterols was effected with a single chromatographic run with n-hexane extracts of plasma or lipoprotein fraction. The separation and determination of these fat-soluble components required as little as 5 microliters of plasma or lipoprotein fraction.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2283380     DOI: 10.1016/s0021-9673(01)89358-4

Source DB:  PubMed          Journal:  J Chromatogr


  2 in total

1.  Lipid peroxidation of isolated chylomicrons and oxidative status in plasma after intake of highly purified eicosapentaenoic or docosahexaenoic acids.

Authors:  J B Hansen; R K Berge; A Nordøy; K H Bønaa
Journal:  Lipids       Date:  1998-11       Impact factor: 1.880

2.  Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease.

Authors:  J Poirier; M C Delisle; R Quirion; I Aubert; M Farlow; D Lahiri; S Hui; P Bertrand; J Nalbantoglu; B M Gilfix; S Gauthier
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.